TransCelerate accreditation

TransCelerate Accreditation

ICH GCP training (Good Clinical Practice E6 (R3)) performed by BioResearch, which is dedicated for our employees and external entities, was accredited by TransCelerate Biopharma Inc. and so we joined „GCP Mutual Recognition Program"

TransCelerate organisation aim is to unify GCP trainings for Research Teams and confirms that registered trainings fulfill basic program requirements.

GCP certificates which are issued after finishing the training are accepted by Sponsors and representatives of pharmaceuticals companies all over teh world.

BioResearch training was placed on the list of trainings of Transcelerate Biopharma Inc, which is presented at following link: http://www.transceleratebiopharmainc.com/gcp-training-attestation/training-providers/

What makes the training in BioResearch unique and valuable?

Practical approach supported by many years of experience of the Speakers, who as researchers carried out dozens of projects.

Aim

Preparation of researchers and research centers to perform delegated duties in accordance with GCP, local and international law.

To whom

To experienced and beginning researchers, research team: coordinators, pharmacists, lab technicians, nurses and other involved in the project.

Go back

News

Increasing Access to Breakthrough Clinical Trials for Patients in Poland

Poland is strengthening its position as one of the leading clinical research hubs in Europe

Read more …

Happy Easter from BioResearch Group

On the occasion of Easter, we would like to extend our warmest wishes of peace, joy, and renewed energy

Read more …

Clinical research reshapes nicotine regulation – new publication by BRG CEO

BioResearch Group (BRG) announces the publication of a new article by Dr Katarzyna Jarus-Dziedzic.

Read more …

BRG’s Contribution to the Advancement of an Innovative Therapy

Phase I clinical trials conducted at BRG play a key role in the development of new therapies

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲